Abstract-Obesity 3,4 has been associated with increased morbidity and mortality. However, low sensitivity of standard voltage criteria for detection of LV hypertrophy (LVH) has limited utility of the ECG for identification of patients with LVH. [5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20] Although Cornell voltage criteria modestly improve ECG detection of LVH in hypertensive patients, 6,7 the product of Cornell voltage and QRS duration (Cornell voltage-duration product), 8,9 an approximation of the area under the QRS, 10 appears to further enhance sensitivity of the ECG for LVH while maintaining high specificity. As a consequence, Cornell voltage-duration product criteria were used in combination with SokolowLyon voltage 5 to identify hypertensive patients at increased risk of subsequent cardiovascular morbidity and mortality for inclusion in the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study, a prospective trial designed to compare the efficacy of losartan and atenolol in reducing the risk of cardiovascular events. 21,22 Obesity has been associated with increases in LV wall thickness, LV mass, and the prevalence of echocardiographic LVH, independent of the impact of blood pressure. [23][24][25][26] Conversely, obesity has been shown to decrease sensitivity of precordial lead ECG criteria for LVH, presumably because of the attenuating effects of increased distance of exploring electrodes from the LV and attenuation of QRS amplitudes by interposed tissue. 11,14 -20 However, obesity is common in hypertensive patients, [23][24][25][26] raising questions regarding the utility of precordial voltage criteria in detecting hypertensive LVH. Moreover, previous studies of the impact of increased